BSECompany Update1d ago · 23 Oct 2026, 07:44 pm
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and any other applicable provisions, please note the schedule of earnings call below, for the quarter and half year ended September 30, 2026
RPG Life Sciences Ltd · 532983
✦ AI SummaryResults
RPG Life Sciences Ltd has announced the schedule of earnings call for the quarter and half year ended September 30, 2026, to be held on October 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
1eb5295b-bc65-4b63-a581-adaf797c42c9.pdf
View document text
October 23, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, 5th Floor, Corporate Relationship Department
Plot No. C-1, G- Block, 25, P.J. Towers,
Bandra - Kurla Complex, Bandra (East) Dalal Street,
Mumbai – 400 051. Mumbai 400 001.
Symbol: RPGLIFE Scrip Code: 532983
Dear Sir/Madam,
Sub: Earnings Call for Unaudited Financial Results.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, and any other applicable provisions, please note the schedule of earnings call below, for the quarter
and half year ended September 30, 2026:
Date Time (IST) Details/Host Venue/Mode Nature of
Meeting
October 30, 2026 05.00 P.M. Q2 FY27 Results- Virtual (over call) Group Meet
Earnings Call
The dial-in details are enclosed herewith.
The investor presentation shall be shared separately.
It is requested to take the same on record and disseminate appropriately.
Thanking you,
Yours faithfully,
For RPG Life Sciences Limited
Rajesh Shirambekar
Head – Legal & Company Secretary
Encl: a/a
You are cordially invited to the
Conference Call of
RPG Lifesciences Limited
Friday, October 30, 2026 at 5:00PM IST
Represented by:
Mr. Ashok Nair Managing Director
Mr. Amol Lone Chief Financial Officer
Pre-register to avoid the waiting queue, join with DiamondPass link: Registration Link
Conference Dial-In Number
+91 22 6280 1116
Universal Access
+91 22 7115 8017
Hong Kong: 800 964 448
Singapore: 800 101 2045
International Toll Free
USA: 1 866 746 2133
UK: 0 808 101 1573
For further information, please contact:
Rashmi Shetty Candice Pereira Zain Gulam Hussain
Director - Research AVP Research Associate
Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd.
(D) +91 22 40969724 (D) +91 22 61764873 (D) +91 22 40969790
(M) +91 22 8879111413 (M) +91 22 9833458572 (M) +91 22 9892724209
Email: rashmis@dolatcapital.com Email: candicep@dolatcapital.com Email: zain@dolatcapital.com